MoonLake Immunotherapeutics (MLTX) had the highest return in February 2023 by a US stock with a market cap of $2B+, returning 60.6%.
| ASSET | MONTH | % RETURN |
|---|---|---|
MoonLake Immunotherapeutics (MLTX) | February 2023 | 60.59% |
SoundHound AI (SOUN) | February 2023 | 48.68% |
Oscar Health (OSCR) | February 2023 | 44.65% |
VEON (VEON) | February 2023 | 42.46% |
Intapp (INTA) | February 2023 | 36.62% |
Hims Hers Health (HIMS) | February 2023 | 36.11% |
Super Micro Computer (SMCI) | February 2023 | 36.07% |
Torm PLC Class A (TRMD) | February 2023 | 35.45% |
Frontline (FRO) | February 2023 | 32.96% |
ELF Beauty (ELF) | February 2023 | 30.25% |
Iris Energy (IREN) | February 2023 | 28.84% |
Lantheus (LNTH) | February 2023 | 28.38% |
DraftKings (DKNG) | February 2023 | 25.4% |
Viking Therapeutics (VKTX) | February 2023 | 24.97% |
Scorpio Tankers (STNG) | February 2023 | 24.94% |
ACV Auctions (ACVA) | February 2023 | 24.9% |
Apellis Pharmaceuticals (APLS) | February 2023 | 24.46% |
Materion (MTRN) | February 2023 | 24.1% |
BridgeBio Pharma (BBIO) | February 2023 | 22.66% |
ZIM Integrated Shipping Services (ZIM) | February 2023 | 22.59% |
Protagonist Therapeutics (PTGX) | February 2023 | 22.14% |
MYR (MYRG) | February 2023 | 21.94% |
Bausch Health Companies (BHC) | February 2023 | 21.38% |
Samsara (IOT) | February 2023 | 21.34% |
Merus (MRUS) | February 2023 | 20.85% |
